Milestone Pharmaceuticals Inc. Common Shares

MIST XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

140M

Short interest (Jun 30)

10.1%

Net Short (Jul 27 ): -0.1%

Borrow Fee

1.62%

↑ 16.3%

Available Shares

↓ 3.0%

Price Chart

Company Overview

Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001408443

Asset Type: CS

Market Data

Market Cap: $144,417,656

Employees: 38

Status: Active

Short Interest

Current Borrow Fee 1.62%

Range: 1.55% - 1.88%

Available Shares 6M

Range: 5.4M - 5.8M

Recent Changes

Fee Change: ↑ 2.7%

Available Change: ↓ 3.5%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime